Molnupiravir (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Molnupiravir" in Catalan language version.

refsWebsite

Global rank Catalan rank

2^nd place

6^th place

4^th place

7^th place

2clinicaltrials.gov

5,225^th place

7,558^th place

1web.archive.org

1^st place

1^st place

48^th place

162^nd place

1bnnbloomberg.ca

low place

low place

8,771^st place

low place

1arstechnica.com

388^th place

527^th place

1washingtonpost.com

34^th place

147^th place

41^st place

184^th place

arstechnica.com

«Meet molnupiravir, Merck's Thor-inspired pill that hammers COVID», 01-10-2021.

bnnbloomberg.ca

«Merck pushes ahead on COVID-19 treatment, vaccines». , 31-07-2020.

clinicaltrials.gov

ClinicalTrials.gov NCT04575584 Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) First posted 5 October 2020; Update posted 9 September 2021
ClinicalTrials.gov NCT04575597 Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

doi.org

dx.doi.org

«Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine, 11, 515, 10-2019, pàg. eaax5866. DOI: 10.1126/scitranslmed.aax5866. PMC: 6848974. PMID: 31645453.
«Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research, 218, 4-2020, pàg. 16–28. DOI: 10.1016/j.trsl.2019.12.002. PMC: 7568909. PMID: 31945316.

go.com

abcnews.go.com

«Daily pill to treat COVID could be just months away» (en anglès), 29-09-2021. Arxivat de l'original el 2021-09-29.

nih.gov

ncbi.nlm.nih.gov

«Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine, 11, 515, 10-2019, pàg. eaax5866. DOI: 10.1126/scitranslmed.aax5866. PMC: 6848974. PMID: 31645453.
«Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research, 218, 4-2020, pàg. 16–28. DOI: 10.1016/j.trsl.2019.12.002. PMC: 7568909. PMID: 31945316.

statnews.com

«Merck's antiviral pill reduces hospitalization of Covid patients, a possible game-changer for treatment». Stat, 01-10-2021.

usatoday.com

«New antiviral is highly effective, study finds, and is stirring hope that COVID-19 could be treated by a pill». USA Today.

washingtonpost.com

«Merck's experimental pill to treat covid-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports». The Washington Post.

web.archive.org

«Daily pill to treat COVID could be just months away» (en anglès), 29-09-2021. Arxivat de l'original el 2021-09-29.